The link between iron, metabolic syndrome, and Alzheimer's disease (Q37765832)

22 August 2017

1 reference

title

The link between iron, metabolic syndrome, and Alzheimer's disease (English)

1 reference

22 August 2017

0 references

1 reference

Edna Grünblatt

1

0 references

Peter Riederer

series ordinal

3

object named as

Peter Riederer

1 reference

22 August 2017

2

Jasmin Bartl

1 reference

22 August 2017

17 June 2010

1 reference

Journal of Neural Transmission

22 August 2017

1 reference

22 August 2017

118

1 reference

22 August 2017

3

1 reference

22 August 2017

371-379

1 reference

https://scigraph.springernature.com/pub.10.1007/s00702-010-0426-3

22 August 2017

0 references

cites work

Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

2010 Alzheimer's disease facts and figures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Characterization of Copper Interactions with Alzheimer Amyloid β Peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Monocyte NADPH oxidase subunit p22(phox) and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Neural roles for heme oxygenase: contrasts to nitric oxide synthase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

The effect of Zn(II) and streptozotocin administration in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Chronic diabetes increases advanced glycation end products on cardiac ryanodine receptors/calcium-release channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Copper, Zinc, and the Metallobiology of Alzheimer Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Type 2 diabetes: where we are today: an overview of disease burden, current treatments, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Overexpression of metallothionein in pancreatic beta-cells reduces streptozotocin-induced DNA damage and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Association among serum ferritin, alanine aminotransferase levels, and metabolic syndrome in Korean postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Metallothionein in olfactory mucosa of Alzheimer's disease patients and apoE-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Insulin injection increases the levels of serum receptors for transferrin and insulin-like growth factor-II/mannose-6-phosphate in intact rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Molecular connexions between dementia and diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Regional variation in the levels of transferrin in the CNS of normal and myelin-deficient rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Cellular distribution of transferrin, ferritin, and iron in normal and aged human brains

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Regional distribution of iron and iron-regulatory proteins in the brain in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Insulin resistance and Alzheimer's disease pathogenesis: potential mechanisms and implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Insulin Resistance and Iron Overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Alzheimer's disease is type 3 diabetes-evidence reviewed

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Bilirubin, formed by activation of heme oxygenase-2, protects neurons against oxidative stress injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Copper and zinc binding to amyloid-beta: coordination, dynamics, aggregation, reactivity and metal-ion transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Brain insulin and insulin receptors in aging and sporadic Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Potential roles of insulin and IGF-1 in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Generation of hydroxyl radicals mediated by streptozotocin in pancreatic islets of mice in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Association of High Serum Ferritin Concentration with Glucose Intolerance and Insulin Resistance in Healthy People

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Performance of FDG PET for detection of Alzheimer's disease in two independent multicentre samples (NEST-DD and ADNI).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Type 2 diabetes mellitus contributes to cognitive decline in old age: a longitudinal population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Overweight in midlife and risk of dementia: a 40-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Balancing acts: molecular control of mammalian iron metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

21 January 2018

PET studies in dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Roles of the metallothionein family of proteins in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Age-associated increases in heme oxygenase-1 and ferritin immunoreactivity in the autopsied brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Islet amyloid and type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Selenium prevents cognitive decline and oxidative damage in rat model of streptozotocin-induced experimental dementia of Alzheimer's type

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Serum ferritin and risk of the metabolic syndrome in U.S. adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Association between features of the insulin resistance syndrome and Alzheimer's disease independently of apolipoprotein E4 phenotype: cross sectional population based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Risk of dementia among persons with diabetes mellitus: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Iron deposits in multiple sclerosis and Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Metallothionein protects islets from hypoxia and extends islet graft survival by scavenging most kinds of reactive oxygen species

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Optimal cutoff point of glutamate decarboxylase antibody titers in differentiating two subtypes of adult-onset latent autoimmune diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Abeta and human amylin share a common toxicity pathway via mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Adiposity, hyperinsulinemia, diabetes and Alzheimer's disease: an epidemiological perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Hyperinsulinemia and risk of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Effect of streptozotocin-induced diabetes on rat brain mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Peripheral blood stem cell mobilization and apheresis: analysis of adverse events in 94 normal donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

A beneficial role of bile pigments as an endogenous tissue protector: anti-complement effects of biliverdin and conjugated bilirubin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Three histidine residues of amyloid-beta peptide control the redox activity of copper and iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Oxidative changes in the rat brain by intraperitoneal injection of ferric nitrilotriacetate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Association of diabetes mellitus and dementia: the Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

MT-III, a brain-specific member of the metallothionein gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Reactive species and diabetes: counteracting oxidative stress to improve health

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Alzheimer Disease and Oxidative Stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

The metabolic syndrome: definition, global impact, and pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

The role of iron in type 2 diabetes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Tyrosine hydroxylase activity in caudate nucleus from Parkinson's disease: effects of iron and phosphorylating agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Impaired insulin secretion increases the risk of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Glucose metabolism and the risk of Alzheimer's disease and dementia: a population-based 12 year follow-up study in 71-year-old men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Alzheimer-like changes in protein kinase B and glycogen synthase kinase-3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Radical AGEing in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Oxidative damage in Alzheimer's.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Diabetes mellitus and Alzheimer's disease: glycation as a biochemical link

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Iron accumulation in Alzheimer disease is a source of redox-generated free radicals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

The metabolic syndrome: a modern plague spread by modern technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

The role of iron in diabetes and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Localization of transferrin receptors and insulin-like growth factor II receptors in vesicles from 3T3-L1 adipocytes that contain intracellular glucose transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Body iron stores are associated with serum insulin and blood glucose concentrations. Population study in 1,013 eastern Finnish men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Ameliorative effects of dietary caloric restriction on oxidative stress and inflammation in the brain of streptozotocin-induced diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Metal-triggered structural transformations, aggregation, and fibrillation of human alpha-synuclein. A possible molecular NK between Parkinson's disease and heavy metal exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Type 2 diabetes and risk of cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Central obesity and increased risk of dementia more than three decades later

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Diabetes, impaired fasting glucose, and development of cognitive impairment in older women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Metallothionein III is reduced in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Iron, brain ageing and neurodegenerative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Excitotoxicity and oxidative stress during inhibition of energy metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00702-010-0426-3

Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion

21 January 2018

1 reference

12 December 2020

4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

1 reference

12 December 2020

Nitrosamine exposure causes insulin resistance diseases: relevance to type 2 diabetes mellitus, non-alcoholic steatohepatitis, and Alzheimer's disease

1 reference

12 December 2020

Hepatic glucose production and insulin sensitivity and responsiveness in iron-deficient anemic rats.

1 reference

12 December 2020

Insulin elicits a redistribution of transferrin receptors in 3T3-L1 adipocytes through an increase in the rate constant for receptor externalization.

1 reference

12 December 2020

Aluminium, iron, zinc and copper influence the in vitro formation of amyloid fibrils of Abeta42 in a manner which may have consequences for metal chelation therapy in Alzheimer's disease.

1 reference

12 December 2020

Inhibition of the neuronal insulin receptor causes Alzheimer-like disturbances in oxidative/energy brain metabolism and in behavior in adult rats

1 reference

12 December 2020

GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice

1 reference

12 December 2020

Immunocytochemical distribution of transferrin and its receptor in the developing chicken nervous system.

1 reference

12 December 2020

Mechanisms of nitrosamine-mediated neurodegeneration: potential relevance to sporadic Alzheimer's disease

1 reference

12 December 2020

Models of Alzheimer's disease: cellular and molecular aspects

1 reference

12 December 2020

Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat.

1 reference

12 December 2020

Antioxidant defense systems in the brains of type II diabetic mice

1 reference

12 December 2020

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach

1 reference

12 December 2020

Increased insulin sensitivity in iron-deficient rats

1 reference

12 December 2020

C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes

1 reference

12 December 2020

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

1 reference

12 December 2020

Serum ferritin as a component of the insulin resistance syndrome

1 reference

12 December 2020

Adiposity, type 2 diabetes, and Alzheimer's disease

1 reference

12 December 2020

Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis

1 reference

12 December 2020

Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes

1 reference

12 December 2020

Islet redox stress: the manifold toxicities of insulin resistance, metabolic syndrome and amylin derived islet amyloid in type 2 diabetes mellitus.

1 reference

12 December 2020

Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane

1 reference

12 December 2020

Expression of metallothionein-I, -II, and -III in Alzheimer disease and animal models of neuroinflammation.

1 reference

12 December 2020

Altered cerebral energy metabolism in Alzheimer's disease: a PET study.

1 reference

12 December 2020

Transition metal-mediated glycoxidation accelerates cross-linking of beta-amyloid peptide

1 reference

12 December 2020

Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.

1 reference

12 December 2020

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

1 reference

12 December 2020

Subacute nephrotoxicity and induction of renal cell carcinoma in mice treated with ferric nitrilotriacetate.

1 reference

12 December 2020

Radical-promoting "free" iron level in the serum of rats treated with ferric nitrilotriacetate: comparison with other iron chelate complexes

1 reference

12 December 2020

Iron (III) induces aggregation of hyperphosphorylated tau and its reduction to iron (II) reverses the aggregation: implications in the formation of neurofibrillary tangles of Alzheimer's disease.

1 reference

12 December 2020

Zinc sulphate induces metallothionein in pancreatic islets of mice and protects against diabetes induced by multiple low doses of streptozotocin

1 reference

12 December 2020

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

12 December 2020

Epidemilogical trends strongly suggest exposures as etiologic agents in the pathogenesis of sporadic Alzheimer's disease, diabetes mellitus, and non-alcoholic steatohepatitis.

1 reference

12 December 2020

Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra

1 reference

12 December 2020

Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment

1 reference

12 December 2020

Insulin-resistant brain state after intracerebroventricular streptozotocin injection exacerbates Alzheimer-like changes in Tg2576 AbetaPP-overexpressing mice

1 reference

12 December 2020

Inhibition of the neuronal insulin receptor. An in vivo model for sporadic Alzheimer disease?

1 reference

12 December 2020

Desensitization of brain insulin receptor. Effect on glucose/energy and related metabolism.

1 reference

12 December 2020

STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells

1 reference

12 December 2020

Limited Alzheimer-type neurodegeneration in experimental obesity and type 2 diabetes mellitus.

1 reference

12 December 2020

Generation of active oxygen species by iron nitrilotriacetate (Fe-NTA).

1 reference

12 December 2020

Circulating soluble transferrin receptor according to glucose tolerance status and insulin sensitivity

1 reference

12 December 2020

10.1007/S00702-010-0426-3

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20556444